Clicky

CorMedix Inc(CRMD)

Description: CorMedix Inc., a development stage pharmaceutical and medical device company, focuses on in-license, development, and commercialization of therapeutic products for the treatment of cardiac and renal dysfunction primarily in the dialysis and non-dialysis areas. It develops CRMD003 (Neutrolin), an antimicrobial/antifungal and anticoagulant combination in liquid formulation; and CRMD004, gel formulation of Neutrolin for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.


Keywords: Medicine Clinical Medicine CRM Catheter Dialysis Therapeutic Products Hemodialysis Membrane Technology Kidney Dysfunction Stage Pharmaceutical Nephrology Renal Dialysis Pharmaceutical And Medical Device Anticoagulant Rockwell Medical

Home Page: www.cormedix.com

CRMD Technical Analysis

300 Connell Drive
Berkeley Heights, NJ 07922
United States
Phone: 908 517 9500


Officers

Name Title
Dr. Matthew T. David M.D. Exec. VP & CFO
Dr. Phoebe Mounts Esq., Ph.D. EVP, Gen. Counsel, Head of Regulatory, Compliance, Legal & Technical Operations and Sec.
Ms. Elizabeth Masson-Hurlburt B.A. Exec. VP & Head of Clinical Operations
Mr. Joseph Todisco MBA CEO & Director
Donna Ucci Sr. VP & Head of Global Quality

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.7711
Price-to-Sales TTM: 1837.6884
IPO Date: 2010-03-25
Fiscal Year End: December
Full Time Employees: 29
Back to stocks